Physician profile
Arjun Khosla
NPI 1851557573
$4,224.55
in general payments reported to CMS, 2019-2025
35 companies · $681 in 2025
The $681 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $275 · 2021: $496 · 2022: $725 · 2023: $594 · 2024: $884 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,158.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $639.05 | 2019-2024 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $519.54 | 2019-2025 | Erleada |
| Axonics, INC. | $392.54 | 2021-2024 | Axonics |
| Sumitomo Pharma America, INC. | $313.52 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $292.18 | 2019-2025 | |
| Pfizer INC. | $290.20 | 2022-2025 | |
| Myovant Sciences INC. | $237.73 | 2021-2022 | |
| Abbvie INC. | $205.86 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $166.89 | 2019-2024 | Provenge |
| Teleflex LLC | $161.00 | 2021-2023 | Urolift |
| Merck Sharp & Dohme LLC | $121.60 | 2020-2025 | Keytruda |
| Ferring Pharmaceuticals INC. | $115.58 | 2020-2024 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $76.70 | 2024 | Lynparza |
| Novartis Pharmaceuticals Corporation | $70.77 | 2024-2025 | |
| Urovant Sciences INC | $70.58 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $66.97 | 2021 | |
| Convatec INC. | $39.14 | 2025 | |
| Boston Scientific Corporation | $37.78 | 2024-2025 | Rezum Generator, Axonics |
| Civco Medical Instruments | $35.38 | 2025 | |
| Coloplast Corp | $34.63 | 2019 | |
| Antares Pharma, INC. | $34.23 | 2019-2020 | |
| Procept Biorobotics Corporation | $33.26 | 2024 | Aquabeam System |
| Kowa Pharmaceuticals America, INC. | $31.85 | 2023 | Seglentis |
| Acerus Pharmaceuticals Corporation | $31.53 | 2021 | |
| Sun Pharmaceutical Industries INC. | $26.83 | 2023 | Yonsa |
| Blue Earth Diagnostics | $22.72 | 2023 | |
| Baxter Healthcare | $21.71 | 2021 | |
| Bioprotect Medical, INC. | $19.64 | 2025 | Bioprotect Balloon Implant System |
| Telix Pharmaceuticals | $19.57 | 2024 | Illuccix |
| C. R. Bard, INC. & Subsidiaries | $19.55 | 2019 | |
| Tolmar, INC. | $18.84 | 2024 | |
| Genzyme Corporation | $17.74 | 2022 | |
| Endo Pharmaceuticals INC. | $13.81 | 2019 | |
| Myriad Genetic Laboratories, INC. | $13.58 | 2021 | |
| Mission Pharmacal Company | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Khosla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.